The new myokine myonectin is significantly associated with type 2 diabetes in elderly cardiovascular disease patients. (August 2022) - Leiherer, A.; Muendlein, A.; Geiger, K.; Saely, C.H.; Grabher, V.; Fraunberger, P.; Drexel, H.